Respuesta a omalizumab en paciente con neumonía eosinófila crónica y mala respuesta al tratamiento con corticoides

Laviña-Soriano, Eduardo; Ampuero-López, Ana; Izquierdo-Alonso, José Luis.
Arch. bronconeumol. (Ed. impr.) ; 54(7): 393-394, jul. 2018. graf
Artículo en Español | IBECS (España) | ID: ibc-176194

Documentos relacionados

  1. Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.
  2. Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.
  3. 4-Octyl Itaconate Alleviates Airway Eosinophilic Inflammation by Suppressing Chemokines and Eosinophil Development.
  4. [Clinical analysis of chronic eosinophilic pneumonia in 9 cases].
  5. Long-term management and persistent impairment of pulmonary function in chronic eosinophilic pneumonia: A review of the previous literature.
  6. [A CASE OF ALLERGIC RHINITIS WHO HAS DEVELOPED EOSINOPHILIC PNEUMONIA, FOLLOWED BY EOSINOPHILIC CELLULITIS].
  7. Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma.
  8. Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
  9. Results in clinical practice in the treatment of severe eosinophilic asthma with mepolizumab: a real-life study.
  10. Acute Eosinophilic Pneumonia after Combined Use of Conventional and Heat-Not-Burn Cigarettes: A Case Report.